{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T09:44:26Z","timestamp":1775900666126,"version":"3.50.1"},"reference-count":46,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CCR"],"published-print":{"date-parts":[[2020,5,19]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Digoxin has been used for more than 50 years in patients with Atrial Fibrillation (AF),\nwith the goal of Controlling Heart Rate (HR) and restoring sinus rhythm. In the last two decades,\nseveral studies have correlated therapeutic use of digoxin with increased mortality. However, such\nstudies have potential biases that cannot be disregarded, mainly because they are cross-sectional\nexperiments or post-hoc analyses of Randomized Controlled Trials (RCTs). Despite uncertainties\nregarding the safety of digoxin in this setting, it remains one of the most prescribed drugs for AF\nworldwide. On the other hand, the absence of any RCTs designed to evaluate mortality makes a definitive\nconclusion more difficult to reach; therefore, this medication must be used with care. In this\nreview, we explored the therapeutic use of digoxin in the context of AF, discussed mortality data by\nmeans of critical analysis in the light of the best available evidence, and position ourselves in relation\nto more rigorous control of serum levels of this drug in daily practice.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573403x15666190618110941","type":"journal-article","created":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T09:35:48Z","timestamp":1561628148000},"page":"141-146","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Digoxin in Atrial Fibrillation: An Old Topic Revisited"],"prefix":"10.2174","volume":"16","author":[{"given":"Filipe","family":"Ferrari","sequence":"first","affiliation":[{"name":"Graduate Program in Cardiology and Cardiovascular Sciences, School of Medicine, Hospital de Cl\u00ednicas de Porto Alegre (HCPA), Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor R.M.F.","family":"Santander","sequence":"additional","affiliation":[{"name":"Faculty of Medical Sciences of Paraiba, Paraiba, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Stein","sequence":"additional","affiliation":[{"name":"Graduate Program in Cardiology and Cardiovascular Sciences, School of Medicine, Hospital de Cl\u00ednicas de Porto Alegre (HCPA), Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"808","DOI":"10.4330\/wjc.v7.i11.808","volume":"7","author":"Virgadamo S.","year":"2015","unstructured":"Virgadamo S.; Charnigo R.; Darrat Y.; Morales G.; Elayi C.S.; Digoxin: A systematic review in atrial fibrillation, congestive heart failure and post myocardial infarction. World J Cardiol 2015,7(11),808-816","journal-title":"World J Cardiol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1517\/14740338.5.3.453","volume":"5","author":"Tamargo J.","year":"2006","unstructured":"Tamargo J.; Delp\u00f3n E.; Caballero R.; The safety of digoxin as a pharmacological treatment of atrial fibrillation. Expert Opin Drug Saf 2006,5(3),453-467","journal-title":"Expert Opin Drug Saf"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1177\/0897190016642361","volume":"30","author":"Scalese M.J.","year":"2017","unstructured":"Scalese M.J.; Salvatore D.J.; Role of digoxin in atrial fibrillation. J Pharm Pract 2017,30(4),434-440","journal-title":"J Pharm Pract"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s00228-007-0346-9","volume":"63","author":"Hallberg P.","year":"2007","unstructured":"Hallberg P.; Lindb\u00e4ck J.; Lindahl B.; Stenestrand U.; Melhus H.; Digoxin and mortality in atrial fibrillation: a prospective cohort study. Eur J Clin Pharmacol 2007,63(10),959-971","journal-title":"Eur J Clin Pharmacol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijcard.2014.11.112","volume":"180","author":"Pastori D.","year":"2015","unstructured":"Pastori D.; Farcomeni A.; Bucci T.; Cangemi R.; Ciacci P.; Vicario T.; Violi F.; Pignatelli P.; Digoxin treatment is associated with increased total and cardiovascular mortality in anticoagulated patients with atrial fibrillation. Int J Cardiol 2015,180,1-5","journal-title":"Int J Cardiol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/j.cjca.2014.05.009","volume":"30","author":"Chao T.F.","year":"2014","unstructured":"Chao T.F.; Liu C.J.; Chen S.J.; Wang K.L.; Lin Y.J.; Chang S.L.; Lo L.W.; Hu Y.F.; Tuan T.C.; Chen T.J.; Chiang C.E.; Chen S.A.; Does digoxin increase the risk of ischemic stroke and mortality in atrial fibrillation? A nationwide population-based cohort study. Can J Cardiol 2014,30(10),1190-1195","journal-title":"Can J Cardiol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/FJC.0000000000000274","volume":"66","author":"Wang Z.Q.","year":"2015","unstructured":"Wang Z.Q.; Zhang R.; Chen M.T.; Wang Q.S.; Zhang Y.; Huang X.H.; Wang J.; Yan J.H.; Li Y.G.; Digoxin Is associated with increased all-cause mortality in patients with atrial fibrillation regardless of concomitant heart failure: A meta-analysis. J Cardiovasc Pharmacol 2015,66(3),270-275","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"333","DOI":"10.5603\/CJ.a2016.0016","volume":"23","author":"Qureshi W.","year":"2016","unstructured":"Qureshi W.; O\u2019Neal W.T.; Soliman E.Z.; Al-Mallah M.H.; Systematic review and meta-analysis of mortality and digoxin use in atrial fibrillation. Cardiol J 2016,23(3),333-343","journal-title":"Cardiol J"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1177\/1074248415603505","volume":"21","author":"Al-Zakwani I.","year":"2016","unstructured":"Al-Zakwani I.; Panduranga P.; Zubaid M.; Sulaiman K.; Rashed W.A.; Alsheikh-Ali A.A.; AlMahmeed W.; Shehab A.; Al Qudaimi A.; Asaad N.; Amin H.; Impact of digoxin on mortality in patients with atrial fibrillation stratified by heart failure: Findings from gulf survey of atrial fibrillation events in the middle east. J Cardiovasc Pharmacol Ther 2016,21(3),273-279","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1093\/eurheartj\/eht120","volume":"34","author":"Gheorghiade M.","year":"2013","unstructured":"Gheorghiade M.; Fonarow G.C.; van Veldhuisen D.J.; Cleland J.G.; Butler J.; Epstein A.E.; Patel K.; Aban I.B.; Aronow W.S.; Anker S.D.; Ahmed A.; Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial. Eur Heart J 2013,34(20),1489-1497","journal-title":"Eur Heart J"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1136\/hrt.2009.175786","volume":"96","author":"Friberg L.","year":"2010","unstructured":"Friberg L.; Hammar N.; Rosenqvist M.; Digoxin in atrial fibrillation: report from the Stockholm Cohort study of Atrial Fibrillation (SCAF). Heart 2010,96(4),275-280","journal-title":"Heart"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.rec.2014.01.014","volume":"67","author":"Rodr\u00edguez-Ma\u00f1ero M.","year":"2014","unstructured":"Rodr\u00edguez-Ma\u00f1ero M.; Otero-Ravi\u00f1a F.; Garc\u00eda-Seara J.; Zugaza-Gurruchaga L.; Rodr\u00edguez-Garc\u00eda J.M.; Blanco-Rodr\u00edguez R.; Turrado Turrado V.; Fern\u00e1ndez-Villaverde J.M.; Vidal-P\u00e9rez R.C.; Gonz\u00e1lez-Juanatey J.R.; Outcomes of a contemporary sample of patients with atrial fibrillation taking digoxin: results from the AFBAR study. Rev Esp Cardiol (Engl Ed) 2014,67(11),890-897","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.jacc.2017.12.060","volume":"71","author":"Lopes R.D.","year":"2018","unstructured":"Lopes R.D.; Rordorf R.; De Ferrari G.M.; Leonardi S.; Thomas L.; Wojdyla D.M.; Ridefelt P.; Lawrence J.H.; De Caterina R.; Vinereanu D.; Hanna M.; Flaker G.; Al-Khatib S.M.; Hohnloser S.H.; Alexander J.H.; Granger C.B.; Wallentin L.; Digoxin and mortality in patients with atrial fibrillation. J Am Coll Cardiol 2018,71(10),1063-1074","journal-title":"J Am Coll Cardiol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"130","DOI":"10.2174\/1874192401105010130","volume":"5","author":"Currie G.M.","year":"2011","unstructured":"Currie G.M.; Wheat J.M.; Kiat H.; Pharmacokinetic considerations for digoxin in older people. Open Cardiovasc Med J 2011,5,130-135","journal-title":"Open Cardiovasc Med J"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2165\/00129784-200606020-00002","volume":"6","author":"Bauman J.L.","year":"2006","unstructured":"Bauman J.L.; Didomenico R.J.; Galanter W.L.; Mechanisms, manifestations, and management of digoxin toxicity in the modern era. Am J Cardiovasc Drugs 2006,6(2),77-86","journal-title":"Am J Cardiovasc Drugs"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1540-8191.1987.tb00204.x","volume":"2","author":"Bhatia S.J.","year":"1987","unstructured":"Bhatia S.J.; Smith T.W.; Digitalis toxicity: mechanisms, diagnosis, and management. J Card Surg 1987,2(4),453-465","journal-title":"J Card Surg"},{"key":"ref=17","first-page":"180","volume":"253","author":"Rebagay W.R.","year":"1990","unstructured":"Rebagay W.R.; Caldwell R.W.; Different patterns of autonomic nerve activity produced by a polar vs. a neutral cardiac glycoside. J Pharmacol Exp Ther 1990,253(1),180-184","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"35A","DOI":"10.1016\/S0735-1097(85)80461-7","volume":"5","author":"Watanabe A.M.","year":"1985","unstructured":"Watanabe A.M.; Digitalis and the autonomic nervous system. J Am Coll Cardiol 1985,5(5)(Suppl. A),35A-42A","journal-title":"J Am Coll Cardiol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.amjopharm.2010.10.001","volume":"8","author":"Cheng J.W.","year":"2010","unstructured":"Cheng J.W.; Rybak I.; Use of digoxin for heart failure and atrial fibrillation in elderly patients. Am J Geriatr Pharmacother 2010,8(5),419-427","journal-title":"Am J Geriatr Pharmacother"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/HPC.0b013e318221e7dd","volume":"10","author":"Ehle M.","year":"2011","unstructured":"Ehle M.; Patel C.; Giugliano R.P.; Digoxin: clinical highlights: a review of digoxin and its use in contemporary medicine. Crit Pathw Cardiol 2011,10(2),93-98","journal-title":"Crit Pathw Cardiol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.tcm.2016.03.011","volume":"26","author":"Ziff O.J.","year":"2016","unstructured":"Ziff O.J.; Kotecha D.; Digoxin: The good and the bad. Trends Cardiovasc Med 2016,26(7),585-595","journal-title":"Trends Cardiovasc Med"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1056\/NEJM197303292881317","volume":"288","author":"Greenblatt D.J.","year":"1973","unstructured":"Greenblatt D.J.; Duhme D.W.; Koch-Weser J.; Pain and CPX elevation after intramuscular digoxin. N Engl J Med 1973,288(13),689","journal-title":"N Engl J Med"},{"key":"ref=23","first-page":"223","volume":"62","author":"MacLeod-Glover N.","year":"2016","unstructured":"MacLeod-Glover N.; Mink M.; Yarema M.; Chuang R.; Digoxin toxicity: Case for retiring its use in elderly patients? Can Fam Physician 2016,62(3),223-228","journal-title":"Can Fam Physician"},{"key":"ref=24","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002949","volume":"95","author":"Zeng W.T.","year":"2016","unstructured":"Zeng W.T.; Liu Z.H.; Li Z.Y.; Zhang M.; Cheng Y.J.; Digoxin use and adverse outcomes in patients with atrial fibrillation. Medicine (Baltimore) 2016,95(12)","journal-title":"Medicine (Baltimore)"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1186\/s13104-015-1367-6","volume":"8","author":"Renard D.","year":"2015","unstructured":"Renard D.; Rubli E.; Voide N.; Borruat F.X.; Rothuizen L.E.; Spectrum of digoxin-induced ocular toxicity: a case report and literature review. BMC Res Notes 2015,8,368","journal-title":"BMC Res Notes"},{"key":"ref=26","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.1646","volume":"9","author":"Amjad W.","year":"2017","unstructured":"Amjad W.; Qureshi W.; Farooq A.; Sohail U.; Khatoon S.; Pervaiz S.; Narra P.; Hasan S.M.; Ali F.; Ullah A.; Guttmann S.; Gastrointestinal side effects of antiarrhythmic medications: A review of current literature. Cureus 2017,9(9)","journal-title":"Cureus"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1056\/NEJM199702203360801","volume":"336","year":"1997","unstructured":"The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997,336(8),525-533","journal-title":"N Engl J Med"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.jacc.2014.03.060","volume":"64","author":"Turakhia M.P.","year":"2014","unstructured":"Turakhia M.P.; Santangeli P.; Winkelmayer W.C.; Xu X.; Ullal A.J.; Than C.T.; Schmitt S.; Holmes T.H.; Frayne S.M.; Phibbs C.S.; Yang F.; Hoang D.D.; Ho P.M.; Heidenreich P.A.; Increased mortality associated with digoxin in contemporary patients with atrial fibrillation: findings from the TREAT-AF study. J Am Coll Cardiol 2014,64(7),660-668","journal-title":"J Am Coll Cardiol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1016\/j.jacc.2015.04.045","volume":"65","author":"Allen L.A.","year":"2015","unstructured":"Allen L.A.; Fonarow G.C.; Simon D.N.; Thomas L.E.; Marzec L.N.; Pokorney S.D.; Gersh B.J.; Go A.S.; Hylek E.M.; Kowey P.R.; Mahaffey K.W.; Chang P.; Peterson E.D.; Piccini J.P.; Digoxin use and subsequent outcomes among patients in a contemporary atrial fibrillation cohort. J Am Coll Cardiol 2015,65(25),2691-2698","journal-title":"J Am Coll Cardiol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1093\/eurheartj\/ehs348","volume":"34","author":"Whitbeck M.G.","year":"2013","unstructured":"Whitbeck M.G.; Charnigo R.J.; Khairy P.; Ziada K.; Bailey A.L.; Zegarra M.M.; Shah J.; Morales G.; Macaulay T.; Sorrell V.L.; Campbell C.L.; Gurley J.; Anaya P.; Nasr H.; Bai R.; Di Biase L.; Booth D.C.; Jondeau G.; Natale A.; Roy D.; Smyth S.; Moliterno D.J.; Elayi C.S.; Increased mortality among patients taking digoxin--analysis from the AFFIRM study. Eur Heart J 2013,34(20),1481-1488","journal-title":"Eur Heart J"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1093\/eurheartj\/ehv143","volume":"36","author":"Vamos M.","year":"2015","unstructured":"Vamos M.; Erath J.W.; Hohnloser S.H.; Digoxin-associated mortality: a systematic review and meta-analysis of the literature. Eur Heart J 2015,36(28),1831-1838","journal-title":"Eur Heart J"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1161\/CIRCEP.114.002292","volume":"8","author":"Freeman J.V.","year":"2015","unstructured":"Freeman J.V.; Reynolds K.; Fang M.; Udaltsova N.; Steimle A.; Pomernacki N.K.; Borowsky L.H.; Harrison T.N.; Singer D.E.; Go A.S.; Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study. Circ Arrhythm Electrophysiol 2015,8(1),49-58","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"ref=33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0193924","volume":"13","author":"Sethi N.J.","year":"2018","unstructured":"Sethi N.J.; Nielsen E.E.; Safi S.; Feinberg J.; Gluud C.; Jakobsen J.C.; Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials. PLoS One 2018,13(3)","journal-title":"PLoS One"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.amjcard.2018.09.036","volume":"123","author":"Vamos M.","year":"2019","unstructured":"Vamos M.; Erath J.W.; Benz A.P.; Lopes R.D.; Hohnloser S.H.; Meta-analysis of effects of digoxin on survival in patients with atrial fibrillation or heart failure: An update. Am J Cardiol 2019,123(1),69-74","journal-title":"Am J Cardiol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5935\/abc.20160055","volume":"106","author":"Magalh\u00e3es L.P.","year":"2016","unstructured":"Magalh\u00e3es L.P.; Figueiredo M.J.O.; Cintra F.D.; II diretrizes brasileiras de fibrila\u00e7\u00e3o atrial. Arq Bras Cardiol 2016,106(4)(Suppl. 2),1-22","journal-title":"Arq Bras Cardiol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"29060","DOI":"10.3390\/ijms161226147","volume":"16","author":"Tariq S.","year":"2015","unstructured":"Tariq S.; Aronow W.S.; Use of inotropic agents in treatment of systolic heart failure. Int J Mol Sci 2015,16(12),29060-29068","journal-title":"Int J Mol Sci"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1001\/jamainternmed.2013.10432","volume":"174","author":"Goldberger Z.D.","year":"2014","unstructured":"Goldberger Z.D.; Alexander G.C.; Digitalis use in contemporary clinical practice: refitting the foxglove. JAMA Intern Med 2014,174(1),151-154","journal-title":"JAMA Intern Med"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1016\/S0140-6736(14)61836-5","volume":"385","author":"Washam J.B.","year":"2015","unstructured":"Washam J.B.; Stevens S.R.; Lokhnygina Y.; Halperin J.L.; Breithardt G.; Singer D.E.; Mahaffey K.W.; Hankey G.J.; Berkowitz S.D.; Nessel C.C.; Fox K.A.; Califf R.M.; Piccini J.P.; Patel M.R.; Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF). Lancet 2015,385(9985),2363-2370","journal-title":"Lancet"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.amjcard.2007.02.099","volume":"100","author":"Ahmed A.","year":"2007","unstructured":"Ahmed A.; Gambassi G.; Weaver M.T.; Young J.B.; Wehrmacher W.H.; Rich M.W.; Effects of discontinuation of digoxin vs. continuation at low serum digoxin concentrations in chronic heart failure. Am J Cardiol 2007,100(2),280-284","journal-title":"Am J Cardiol"},{"key":"ref=40","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.009509","volume":"7","author":"Pastori D.","year":"2018","unstructured":"Pastori D.; Carnevale R.; Nocella C.; Bartimoccia S.; Novo M.; Cammisotto V.; Piconese S.; Santulli M.; Vasaturo F.; Violi F.; Pignatelli P.; Digoxin and platelet activation in patients with atrial fibrillation: In vivo and in vitro study. J Am Heart Assoc 2018,7(22)","journal-title":"J Am Heart Assoc"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1681\/ASN.2009101047","volume":"21","author":"Chan K.E.","year":"2010","unstructured":"Chan K.E.; Lazarus J.M.; Hakim R.M.; Digoxin associates with mortality in ESRD. J Am Soc Nephrol 2010,21(9),1550-1559","journal-title":"J Am Soc Nephrol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0272-6386(85)80139-6","volume":"5","author":"Papadakis M.A.","year":"1985","unstructured":"Papadakis M.A.; Wexman M.P.; Fraser C.; Sedlacek S.M.; Hyperkalemia complicating digoxin toxicity in a patient with renal failure. Am J Kidney Dis 1985,5(1),64-66","journal-title":"Am J Kidney Dis"},{"key":"ref=43","volume":"16","author":"Lindenfeld J.","year":"2010","unstructured":"Lindenfeld J.; Albert N.M.; Boehmer J.P.; Collins S.P.; Ezekowitz J.A.; Givertz M.M.; Katz S.D.; Klapholz M.; Moser D.K.; Rogers J.G.; Starling R.C.; Stevenson W.G.; Tang W.H.; Teerlink J.R.; Walsh M.N.; HFSA 2010 Comprehensive Heart Failure Practice Guideline. J Card Fail 2010,16(6)","journal-title":"J Card Fail"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","volume":"64","author":"January C.T.","year":"2014","unstructured":"January C.T.; Wann L.S.; Alpert J.S.; Calkins H.; Cigarroa J.E.; Cleveland J.C.; Conti J.B.; Ellinor P.T.; Ezekowitz M.D.; Field M.E.; Murray K.T.; Sacco R.L.; Stevenson W.G.; Tchou P.J.; Tracy C.M.; Yancy C.W.; 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2014,64(21),e1-e76","journal-title":"J Am Coll Cardiol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","volume":"37","author":"Kirchhof P.","year":"2016","unstructured":"Kirchhof P.; Benussi S.; Kotecha D.; Ahlsson A.; Atar D.; Casadei B.; Castella M.; Diener H.C.; Heidbuchel H.; Hendriks J.; Hindricks G.; Manolis A.S.; Oldgren J.; Popescu B.A.; Schotten U.; Van Putte B.; Vardas P.; 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 2016,37(38),2893-2962","journal-title":"Eur Heart J"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"436","DOI":"10.5935\/abc.20180190","volume":"111","author":"Rohde L.E.P.","year":"2018","unstructured":"Rohde L.E.P.; Montera M.W.; Bocchi E.A.; Clausell N.O.; Albuquerque D.C.; Rassi S.; Colafranceschi A.S.; Freitas A.F.; Ferraz A.S.; Biolo A.; Barretto A.C.P.; Ribeiro A.L.P.; Polanczyk C.A.; Gualandro D.M.; Almeida D.R.; Silva E.R.R.; Figueiredo E.L.; Mesquita E.T.; Marcondes-Braga F.G.; Cruz F.D.D.; Ramires F.J.A.; Atik F.A.; Bacal F.; Souza G.E.C.; Almeida G.L.G.; Ribeiro G.C.A.; Villacorta H.; Vieira J.L.; Souza J.D.; Rossi J.M.; Figueiredo J.A.; Moura L.A.Z.; Goldraich L.A.; Beck-da-Silva L.; Danzmann L.C.; Canesin M.F.; Bittencourt M.I.; Garcia M.I.; Bonatto M.G.; Sim\u00f5es M.V.; Moreira M.C.V.; Silva M.M.F.; Olivera M.T.; Silvestre O.M.; Schwartzmann P.V.; Bestetti R.B.; Rocha R.M.; Sim\u00f5es R.; Pereira S.B.; Mangini S.; Alves S.M.M.; Ferreira S.M.A.; Issa V.S.; Barzilai V.S.; Martins W.A.; Diretriz brasileira de insufici\u00eancia card\u00edaca cr\u00f4nica e aguda. Arq Bras Cardiol 2018,111(3),436-539","journal-title":"Arq Bras Cardiol"}],"container-title":["Current Cardiology Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/172692","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T04:51:26Z","timestamp":1594270286000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/172692\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,19]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,5,19]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573403x15666190618110941","relation":{},"ISSN":["1573-403X"],"issn-type":[{"value":"1573-403X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5,19]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-03-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-28","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}